top of page

CONTINUUS Pharmaceuticals Secures $69.3 Million Government Contract to Manufacture Critical Medicines in the U.S.

Thursday, January 21st, 2021 - General News

DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19. CONTINUUS will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines Click here for full press release

Recent Posts

See All

CONTINUUS ON SHOW AT CHPI 2022

Monday, September 26th, 2022 - General News CPHI 2022 is just around the corner and CONTINUUS is pleased to be part of it! From November...

Bình luận


bottom of page